Professor Sam Salek

Emeritus Professor of Pharmacoepidemiology

1990 …2025

Research activity per year

Network

A. Y. Finlay

  • HEI: Cardiff University

External person

Stuart R. Walker

  • Centre for Innovation in Regulatory Science
  • HEI: Cardiff University

External person

S Walker

  • Centre for Innovation in Regulatory Science

External person

Francoise Poot

  • Universite Libre de Bruxelles Erasme Hospital

External person

Andrew Y. Finlay

  • HEI: Cardiff University

External person

Andrew Y. Finlay

  • HEI: Cardiff University

External person

Lucia Tomas-Aragones

  • Aragon Health Sciences Institute

External person

Jacek C. Szepietowski

  • Wroclaw Medical University

External person

Joerg Kupfer

  • Justus Liebig University Giessen

External person

Uwe Gieler

  • Justus Liebig University Giessen

External person

Gregor B.E. Jemec

  • Zealand University Hospital

External person

Nutjaree Johns

  • Faculty of Pharmaceutical Sciences and Melatonin Research Group, Khon Kaen University, Khon Kaen, Thailand.

External person

Flora Balieva

  • Stavanger University Hospital

External person

Jon Anders Halvorsen

  • Oslo University Hospital
  • University of Oslo

External person

P. Kamudoni

  • Institute of Medicines Development

External person

Laurent Misery

  • University Hospital of Brest

External person

Nicola Allen

  • Centre for Innovation in Regulatory Science
  • HEI: Cardiff University

External person

F. M. Ali

  • HEI: Cardiff University

External person

Dennis Linder

  • University of Oslo

External person

Tatyana Ionova

  • National Medical Surgical Centre and Multinational Center for Quality of Life Research, St Petersburg

External person

Esther Natalie Oliva

  • Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli di Reggio Calabria

External person

Florence Dalgard

  • Lund University
  • Innlandet Hospital Trust

External person

Servando E. Marron

  • Alcaniz Hospital

External person

Faraz Mahmood Ali

  • HEI: Cardiff University

External person

N McAuslane

  • Centre for Innovation in Regulatory Science (CIRS), London

External person

SE Marron

  • Department of Dermatology, Royo Villanova Hospital, Zaragoza

External person

Lawrence Liberti

  • Centre for Innovation in Regulatory Science

External person

Ilknur K. Altunay

  • Health Sciences University

External person

Lars Lien

  • Innlandet Hospital Trust

External person

Stuart D. Walker

  • HEI: The University of Essex

External person

V. Piguet

  • HEI: Cardiff University

External person

Henriët Van Middendorp

  • Leiden University

External person

Sophie Staniszewska

  • HEI: University of Warwick

External person

Csanád Szabó

  • University of Szeged

External person

Hasumati Rahalkar

  • Department of Pharmacy, Pharmacology, Clinical Science, University of Hertfo rdshire, Herts, UK Herts. United Kingdom.

External person

Kirstie Haywood

  • HEI: University of Warwick
  • Warwick Medical School

External person

M Bujar

  • Centre for Innovation in Regulatory Science (CIRS), London
  • Department of Pharmacy, Pharmacology and Postgraduate Medicine, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK.

External person

J Leong

  • Center of Regulatory Excellence, Duke-NUS Graduate Medical School Singapore

External person

N. A. Harun

  • HEI: Cardiff University

External person

Vincent Piguet

  • HEI: Cardiff University

External person

Lars Lien

  • Department of Public Health, Hedmark University College, Elverum,

External person

B. Mueller

  • RIEMSER Pharma GmbH

External person

Esther Oliva

  • Hematology Unit, Azienda Ospedaliera, Reggio Calabria

External person

R Donelan

  • Global Regulatory Affairs, Quintiles, Dublin

External person

Jacek C Szepietowski

  • Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland.

External person

GP Collins

  • NHS - Haematology, Oxford University Hospitals NHS Trust, Oxford

External person

RJ Klaassen

  • Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontari

External person

Walker Stuart

  • Department of Pharmacy, Pharmacology, Clinical Science, University of Hertfo rdshire, Herts, UK Herts. United Kingdom.

External person

L Kemeny

  • Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary; Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged

External person

J Kell

  • Haematology, Cardiff & Vale University Health Board, Cardiff

External person

S McConnell

  • NHS - Leeds Teaching Hospitals NHS Trust

External person

M Karakantza

  • NHS - Leeds Teaching Hospitals NHS Trust

External person

A Keyter

  • Department of Pharmacy, Pharmacology, Clinical Science, University of Hertfo rdshire, Herts, UK Herts. United Kingdom.

External person

S Al-Ismail

  • Haematology, Singleton Hospital, ABM University Health Board, Swansea

External person

Andrea Keyter

  • Department of Health, South African Health Products Regulatory Authority, Pretoria, South Africa

External person

Dmitry Romanov

  • I. M. Sechenov First Moscow State Medical University

External person

AK Fielding

  • University College London (UCL) Cancer Institute, Haematology

External person

Sarah Lussier Hoskyn

  • Innovative Medicines Canada, Ottawa

External person

Shabir Banoo

  • Department of Health, South African Health Products Regulatory Authority, Pretoria, South Africa
  • Department of Pharmacy and Pharmacology, University of the Witwatersrand, Johannesburg, South Africa,

External person

Maarten de Wit

  • Department of Medical Humanities, VU University, Amsterdam

External person

RF Grace

  • Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts

External person

R Else

  • Patient Research Partner, Milton Keynes, UK.

External person

DM Jennings

  • NHS - Haematology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey

External person

MJ Santana

  • W21C Research and Innovation Centre, Faculty of Medicine, University of Calgary

External person

Areewan Cheawchanwattana

  • 3 Faculty of Pharmaceutical Sciences, Khon Kaen University , Khon Kaen, Thailand .

External person

M Machaczka

  • Medical Faculty, University of Rzeszow, Rzeszow, Poland, and Hematology Center Karolinska and Department of Medicine at Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm

External person

J Bright

  • Research Evaluation Unit, Oxford Pharmagenesis, Tubney

External person

C Penman

  • HEI: The University of Bristol

External person

Anita Altmayer

  • University of Szeged

External person

S Spillekom-van Koulil

  • Department of Medical Psychology, Radboud University Medical Center, Nijmegen

External person

S Walker

  • HEI: Cardiff University

External person

N Marlett

  • Community Rehabilitation and Disability Studies, Cummings School of Medicine, University of Calgary, Floor 3, TRW Building, 3280 Hospital Drive, NW, Calgary

External person

T Ternowitz

  • Department of Dermatology, Stavanger University Hospital, Stavanger, Norway.

External person

Jin S. Jung

  • GIST, Gwangju Institute of Science & Technology, Dept Environm Sci & Engn, ADEMRC, Adv Environm Monitoring Res Ctr

External person

A Ryan

  • Endpoint Outcomes, Boston
  • HEI: University College London (UCL)

External person

Rod Middleton

  • HEI: Swansea University

External person

DA Hughes

  • Lysosomal Storage Disorders Unit, Department of Haematology, Royal Free Hospital, UCL Medical School, London

External person

J Brett

  • Oxford Brookes University

External person

J Pérez-López

  • Errores Congénitos del Metabolismo del Adulto, Unidad de Enfermedades Minoritarias, Hospital Universitario Vall d'Hebron, CSUR de Errores Congénitos del Metabolismo, Barcelona
  • Departamento de Astronomia, Universidad de Chile

External person

G Pastores

  • University College Dublin and The Mater Misericordiae University Hospital, Dublin

External person

S Vom Dahl

  • Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf, Düsseldorf

External person

J Gouws

  • Department of Health, Medicines Control Council

External person

A. Schouveller

  • Hyperhidrosis Patient Forum

External person

Robert Falcone

  • School of Life and Medical Science

External person

J. Halford

  • The Hyperhidrosis Support Group UK

External person

B. Stacey

  • Hyperhidrosis Patient Forum

External person

K Nakamura

  • Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto

External person

N Campbell

  • HEI: Cardiff University

External person

David Kuter

  • Center for Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

External person

A Nagral

  • Department of Gastroenterology, Jaslok Hospital and Research Centre, Mumbai

External person

Adam Reich

  • Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland.

External person

S Bodie

  • Agios Pharmaceuticals, Inc, Cambridge, Massachusetts

External person

O Goker-Alpan

  • Lysosomal Disorders Unit and CFCT, O&O Alpan LLC, Fairfax, VA

External person

FM Ali

  • HEI: Cardiff University

External person

E Mengel

  • HEI: Johannes Gutenberg University Mainz

External person

Suphat Subongkot

  • Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand

External person

bozena michniak-kohn

  • Rutgers University

External person

S Riley

  • Institute of Nephrology, University Hospital of Wales, Cardiff

External person

R Moore

  • Consultant Physician and Nephrologist, Tairawhiti District Hospital, Gisborne

External person

B Bembi

  • Centre for Rare Diseases, Academic Medical Centre Hospital of Udine, Udine

External person

NJ Weinreb

  • University of Miami Miller School of Medicine, Department of Human Genetics and Medicine (Hematology), UHealth Sylvester Coral Springs, Coral Springs, FL

External person

Géraldine Titeca

  • Notre-Dame de Grâce Clinic, Gosselies

External person

Kosin Wirasorn

  • Medicine Unit, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

External person

EA Lukina

  • Department of Orphan Diseases, National Research Center for Hematology, Moscow

External person

N Potekaev

  • Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia.

External person

Samantha J. Brace-McDonnell

  • HEI: University of Warwick

External person

J Szer

  • Department of Clinical Haematology & Bone Marrow Transplant Service, The Royal Melbourne Hospital, Melbourne

External person

M Oblak

  • Haematology, West Middlesex University Hospital, Isleworth

External person

L Cohen

  • Patient advocate, Wrentham, Massachusetts

External person

S Shklarov

  • Community Rehabilitation and Disability Studies, Cummings School of Medicine, University of Calgary, Floor 3, TRW Building, 3280 Hospital Drive, NW, Calgary

External person

Hacer Coskun Cetintas

  • Department of Marketing Authorization of Medicines, Turkish Medicines and Medical Devices Agency, Ankara

External person

Nidine Aawar

  • HEI: Cardiff University

External person

John R. Kirwan

  • University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK

External person

IV Schwartz

  • Medical Genetics Service - HCPA, Genetics Department - UFRGS, Porto Alegre-, RS

External person

Aumkhae Sookprasert

  • Medicine Unit, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

External person

Karolina Lesner

  • Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland.

External person

P Chernyshov

  • Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine.

External person

B Witherspoon

  • Endpoint Outcomes, Boston

External person

D Linder

  • Department for Dermatology, Padua University Hospital, Padua

External person

E.R. Davies

  • NHS - Imperial College Healthcare NHS Trust

External person

T Wells

  • Endpoint Outcomes, Boston

External person

B Oliveri

  • Laboratorio de Enfermedades Metabólicas Oseas, INIGEM, UBA-CONICET, Hospital de Clínicas, Buenos Aires

External person

F Deodato

  • Division of Metabolism, Department of Pediatric Specialist, Bambino Gesù Children's Hospital, IRCCS, Rome

External person

MH Al-Rubaie

  • Oman Ministry of Health

External person

J Lyness

  • Haematology, Singleton Hospital, ABM University Health Board, Swansea

External person

M Di Rocco

  • Unit of Rare Diseases, Department of Pediatrics, IRCCS Giannina Gaslini Institute, Genoa

External person

S Egan

  • Endpoint Outcomes, Boston

External person

Srivieng Pairojkul

  • Palliative Care Unit, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

External person

IK Alturnay

  • University of Health Science, Istanbul Sisli Hamidiye Efdal Health Training and Research Centre, Istanbul

External person

Pattariya Chantarasap

  • The College of Pharmacotherapy of Thailand, Nonthaburi, Thailand

External person

Atul Mehta

  • Lysosomal Storage Disorders Unit, Department of Haematology, Royal Free Hospital, UCL Medical School, London

External person

A Zimran

  • Shaare Zedek Medical Center and Hadassah Medical School, Jerusalem

External person

Daniel Baker

  • University of Hertfordshire

External person

E Brenaut

  • Department of Dermatology, University Hospital, Brest

External person

Catherine Langton

  • NHS - Leeds Teaching Hospitals NHS Trust

External person

Christina Schut

  • Institute of Medical Psychology, Justus-Liebig-University, Klinikstraße 29, DE-35392 Gießen

External person

U Ramaswami

  • Lysosomal Storage Disorders Unit, Department of Haematology, Royal Free Hospital, UCL Medical School, London

External person

MJ Al-Obaidi

  • Haematology, West Middlesex University Hospital, Isleworth

External person

Reem K Al-Essa

  • Ministy of Health, Kuwait

External person

N Belmatoug

  • Hôpitaux Universitaires Paris Nord Val de Seine, Hôpital Beaujon, Paris

External person

Mohammed Al-Rubaie

  • Directorate General of Pharmaceutical affairs and Drug Control, Oman Ministry of Health

External person

A Narita

  • Department of Child Neurology, Faculty of Medicine, Tottori University Yon ago

External person

Richard Kay

  • HEI: Cardiff University

External person

Thomas Morel

  • UCB Biopharma, Brussels

External person